Document is current
Any future updates will be listed below
-
Authors
Koseki, Yusuke
Hatakeyama, Keiichi
Terashima, Masanori https://orcid.org/0000-0002-2967-8267
Nagashima, Takeshi
Urakami, Kenichi
Ohshima, Keiichi
Aizawa, Daisuke
Sugino, Takashi
Furukawa, Kenichiro
Fujiya, Keiichi
Tanizawa, Yutaka
Bando, Etsuro
Okamura, Yukiyasu
Akiyama, Yasuto
Yamaguchi, Ken
- License Information
-
More Information
Article History
Received: 20 December 2022
Accepted: 1 April 2023
First Online: 10 April 2023
Declarations
:
: MT has received honorarium from Taiho Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol Myers Squib Japan K.K., Yakult Honsha Co., Ltd, Takeda Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., Pfizer Japan Inc., Daiichi Sankyo Ltd., Johnson and Johnson K.K., Medtronic Japan Co., Ltd., Intuitive Japan Inc., and Olympus Co., Ltd. EB has received honorarium from EIZO Corporation, TERUMO CORPORATION, and EIZAI.
: All procedures were conducted in accordance with the ethical standards of the corresponding committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. The institutional review board at Shizuoka Cancer Center approved all aspects of this study (authorization number 25-33). Informed consent was obtained from all patients.
Free to read: This content has been made available to all.
